Gynecologic Cancer,Other Cancers Lenvatinib + Pembrolizumab in Advanced Endometrial Cancer: Updated KEYNOTE-775 Results May 08, 2023
Other Cancers Selumetinib vs. Placebo: Assessing Complete Remission in Differentiated Thyroid Cancer May 08, 2023
Other Cancers Phase III Trial Comparing 177Lu-Edotreotide with Standard Care for GEP-NETs (Grades 2 and 3) May 08, 2023
Other Cancers Cabozantinib vs Placebo in RAIR DTC Patients: Outcomes by Prior Lenvatinib Duration May 08, 2023
Genitourinary Cancer,Other Cancers Pembrolizumab, Quavonlimab, and Lenvatinib in Treatment of ccRCC May 08, 2023
Genitourinary Cancer,Other Cancers PARP1 and PBRM1 as Biomarkers for Atezolizumab Plus Bevacizumab or Sunitinib Response in RCC May 08, 2023
